Effects of self-monitoring of glucose on distress and self-efficacy in people with non-insulin-treated Type 2 diabetes: a randomized controlled trial.

Autor:	Malanda, U. L., Bot, S. D. M., Kostense, P. J., Snoek, F. J., Dekker, J. M., Nijpels, G.
Předmět:	TYPE 2 diabetes treatment PSYCHOLOGICAL stress BLOOD sugar monitoring CONFIDENCE intervals PEOPLE with diabetes GLYCOSYLATED hemoglobin TYPE 2 diabetes QUESTIONNAIRES RESEARCH funding HEALTH self-care URINALYSIS DATA analysis RANDOMIZED controlled trials TREATMENT effectiveness DIAGNOSIS
Zdroj:	Diabetic Medicine; Apr2016, Vol. 33 Issue 4, p537-546, 10p, 1 Diagram, 3 Charts, 1 Graph
Abstrakt:	Aims To investigate the effects of self-monitoring of glucose in blood or urine, on diabetes-specific distress and self-efficacy, compared with usual care in people with non-insulin-treated Type 2 diabetes mellitus. Methods One hundred and eighty-one participants with non-insulin-treated Type 2 diabetes mellitus [diabetes duration ≥ 1 year, age 45-75 years, HbA1c ≥ 53.0 mmol/mol (7.0%), self-monitoring frequency < 3 times in the previous year] were randomly assigned to blood self-monitoring ( n = 60), urine self-monitoring ( n = 59) or usual care ( n = 62). Primary outcomes were between-group differences in diabetes-specific distress [Problem Areas in Diabetes scale (PAID)] and self-efficacy [Confidence in Diabetes Self-Care questionnaire (CIDS-2)] after 12 months. Secondary outcomes included changes in HbA1c, treatment satisfaction and depressive symptoms. Results There were no statistically significant between-group differences in changes in PAID and CIDS-2 after 12 months. Mean difference in PAID between blood monitoring and control was −2.2 [95% confidence interval (CI) −7.1 to 2.7], between urine monitoring and control was −0.9 (95% CI −4.4 to 2.5) and between blood monitoring and urine monitoring was −2.0 (95% CI −4.1 to 0.1). Mean difference in CIDS-2 between blood monitoring and control was 0.6 [95% CI (−2.0 to 2.1), between urine monitoring and control was 2.8 (95% CI −2.3 to 7.9)] and between blood monitoring and urine monitoring was −3.3 (95% CI −7.9 to 1.3). No statistically significant between-group differences in change in any of the secondary outcome measures were found. Conclusions This study did not find statistical or clinical evidence for a long-term effect of self-monitoring of glucose in blood or urine on diabetes-specific distress and self-efficacy in people with moderately controlled non-insulin-treated Type 2 diabetes mellitus. (Current Controlled Trials ISRCTN84568563) [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text